CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's EPS Net Growth by Quarter and Year

Atara Biotherapeutics,'s EPS Net results by quarter and year




ATRA EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -1.74 -1.15 -0.63
III Quarter September - -1.29 -1.02 -0.88
II Quarter June - -1.15 -0.94 -0.66
I Quarter March -1.44 -1.05 -0.88 -0.58
FY   -1.44 -5.23 -3.99 -2.75



ATRA EPS Net first quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the first quarter recorded EPS net loss of $ -1.44 .

According to the results reported in the first quarter, Atara Biotherapeutics, Inc. achieved the best EPS Net growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s EPS Net no change of % ranks overall at the positon no. in the first quarter.




ATRA EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s first quarter 2019 EPS Net $ -1.44 ATRA's Income Statement
Atara Biotherapeutics,'s first quarter 2018 EPS Net $ -1.05 Quarterly ATRA's Income Statement
New: More ATRA's historic EPS Net Growth >>


ATRA EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q EPS Net Comment
Although Atara Biotherapeutics, Inc. in the I. Quarter 2019 showed EPS net loss of $ -1.44 , some analyst point out, that current results are recovery in contrast to the -1.74 in the forth quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q EPS Net Comment
Despite the fact, that Atara Biotherapeutics, Inc. in the I. Quarter 2019 showed EPS net loss of $ -1.44 , some analyst said, that current results are improvement in contrast to the -1.74 in the forth quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative EPS Net 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
In the period, Atara Biotherapeutics,'s cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ATRA's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ATRA's Competitors
EPS Net Growth for Atara Biotherapeutics,'s Suppliers
EPS Net Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2019
Catalent, Inc.  57.14 %$ 57.143 
Pro Dex Inc  54.55 %$ 54.545 
U S Physical Therapy Inc  44.44 %$ 44.444 
Meridian Bioscience Inc  41.67 %$ 41.667 
Bio-rad Laboratories, Inc.  32.02 %$ 32.017 
Gilead Sciences Inc  31.62 %$ 31.624 
Medpace Holdings, Inc.  27.50 %$ 27.500 
Vertex Pharmaceuticals Inc  27.16 %$ 27.160 
West Pharmaceutical Services Inc  25.86 %$ 25.862 
Mettler Toledo International Inc  23.46 %$ 23.464 
Edwards Lifesciences Corp  22.92 %$ 22.917 
Encompass Health Corp  22.62 %$ 22.619 
Varian Medical Systems Inc  21.52 %$ 21.519 
Amedisys Inc  20.25 %$ 20.253 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MIME's Profile

Stock Price

MIME's Financials

Business Description

Fundamentals

Charts & Quotes

MIME's News

Suppliers

MIME's Competitors

Customers & Markets

Economic Indicators

MIME's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071